ALPHATEC HOLDINGS, INC. Research and Development in Process
ALPHATEC HOLDINGS, INC. (ATEC) reported Research and Development in Process of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2017-03-31
- ALPHATEC HOLDINGS, INC. research and development in process for the quarter ending 2016-12-31 was $0.00.
- ALPHATEC HOLDINGS, INC. research and development in process for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- ALPHATEC HOLDINGS, INC. research and development in process for the quarter ending 2015-12-31 was -$176.00K.
- ALPHATEC HOLDINGS, INC. research and development in process for the quarter ending 2015-09-30 was $274.00K, a 48.01% decline year-over-year.
- ALPHATEC HOLDINGS, INC. research and development in process for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- ALPHATEC HOLDINGS, INC. research and development in process for fiscal 2015 was $98.00K, a 3.92% decline from fiscal 2014.
- ALPHATEC HOLDINGS, INC. research and development in process for fiscal 2014 was $102.00K.
- ALPHATEC HOLDINGS, INC. research and development in process for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 10-K · filed 2017-03-31 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | ||
| 2015-12-31 | -$176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $98.00K derived: sum of 2 quarters · filed 2017-03-31 | $98.00K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $274.00K 10-Q · filed 2016-11-09 | $274.00K 10-Q · filed 2016-11-09 | ||
| 2014-12-31 | -$425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $102.00K derived: sum of 2 quarters · filed 2017-03-31 | $102.00K 10-K · filed 2017-03-31 | |
| 2014-09-30 | $527.00K 10-Q · filed 2016-02-10 | $527.00K 10-Q · filed 2016-02-10 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-10-30 | $0.00 10-Q · filed 2014-10-30 | ||
| 2012-12-31 | $341.00K 10-K · filed 2015-02-27 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-20 | |||
| 2010-12-31 | $1.00M 10-K · filed 2013-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |